Have a personal or library account? Click to login
In vitro reactions with red blood cells that are not due to blood group antibodies: a review Cover

In vitro reactions with red blood cells that are not due to blood group antibodies: a review

By: G. Garratty  
Paid access
|Nov 2020

References

  1. Ley AB, Harris JP,Brinkley M, Liles B, Jack JA, Cahan A. Circulating antibody directed against penicillin. Science 1958;127:1118.10.1126/science.127.3306.1118
  2. Garratty G. Immune cytopenia associated with antibiotics.Trans Med Rev 1993;VII:255–67.10.1016/S0887-7963(93)70145-5
  3. Hysell JK, Gray JM, Hysell JW, Beck ML. An anti-neomycin antibody interfering with ABO grouping and antibody screening. Transfusion 1995;15:16–22.10.1046/j.1537-2995.1975.15175103504.x234642
  4. Beattie KM, Ferguson SJ, Burnie KL, Barr RM, Urbaniak ST, Atherton PJ. Chloramphenicol antibody causing interference in antibody detection and identification tests. Transfusion 1976; 16:174–7.10.1046/j.1537-2995.1976.16276155114.x769257
  5. Hegarty JS, Dolphin E, Leonard WR. Chloramphenicol-dependent antibody with A1 specificity (abstract).Transfusion 1982;22:411.
  6. Fried MR, Scofield TL, Stroncek DF, Swanson JL. Chloramphenicol-dependent antibody: a case report.Transfusion 1996;36:187–90.10.1046/j.1537-2995.1996.36296181933.x8614971
  7. Peloquin PM, Hawkes D,Mayers S.An IgG, gentamicin sulfate-dependent antibody found during prenatal antibody screening.Vox Sang 1986;51:231.10.1159/000461518
  8. Garratty G. Drug-induced immune hemolytic anemia. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Dekker, 1994:523–51.
  9. Garratty G. Immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs. Immunohematology 1994;10:41–50.10.21307/immunohematology-2019-817
  10. Mann JM. Hydrocortisone-associated hemagglutination property of human sera (abstract). Transfusion 1973;13:346.
  11. Pierce SR, Moore A, Hardman J, Beck ML. Hydrocortisone-associated agglutinin masking anti-D in an Rh immune globulin candidate (abstract).Transfusion 1979;19:641.
  12. Williams WD, Lebeck L.An unusual hemagglutinin. Transfusion 1981;21:228–9.10.1046/j.1537-2995.1981.21281178164.x7222207
  13. Pagliaro PP,Veneroni G. Hydrocortisone-associated hemagglutination in a pregnant woman. Transfusion 1989;29:559.10.1046/j.1537-2995.1989.29689318461.x2749880
  14. Pinto V, Fernandez-Fuertes F, Cecchini C, Soto I, Barez A. 11-oxycorticosteroid-dependent antibody in the serum of a patient with bladder neoplasm. Vox Sang 1992;63:227–31.10.1111/j.1423-0410.1992.tb05105.x1448967
  15. Umlas J,Turner LA.Antibodies to hydrocortisone in reagent red cells causing positive antibody screening tests.Transfusion 1993;33:686–88.10.1046/j.1537-2995.1993.33893342753.x8342238
  16. Pinto M, Rimon A. Anti-steroid factor/s in normal and pathological human sera. Vox Sang 1970;18:155–62.10.1111/j.1423-0410.1970.tb01441.x5443631
  17. Gray MP. A human serum factor agglutinating human red cells exposed to lactose. Vox Sang 1964;9:608–16.10.1111/j.1423-0410.1964.tb03331.x14221598
  18. Mougey R, Pierce S, Levy S, Mueller B.A crossmatch problem caused by an antibody reactive with cells stored in sodium lactate (abstract). Transfusion 1980;20:628.
  19. Lewis T, Reid M,Ellisor S,Avoy DR.A glucose-dependent panhemagglutinin.Vox Sang 1980;39:205–11.10.1111/j.1423-0410.1980.tb01858.x7210609
  20. Bird GWG, Roy TCF. Human serum antibodies to melibiose and other carbohydrates. Vox Sang 1980;38:169–71.10.1111/j.1423-0410.1980.tb02346.x7385757
  21. Lalezari P, Jiang AF, Kumar M, Lalezari I. Carbohydrate-specific antibodies in normal human sera. I. Characterization of specificity for β-D-glucose.Vox Sang 1984;47:133–45.10.1111/j.1423-0410.1984.tb01575.x6464415
  22. Morel PA, Bergren MO, Hill V, Garratty G, Perkins HA. M and N specific hemagglutinins of human erythrocytes stored in glucose solutions. Transfusion 1981;21:652–62.10.1046/j.1537-2995.1981.21682085751.x6171920
  23. Reid ME, Ellisor SS, Barker JM, Lewis T, Avoy DR. Characteristics of an antibody causing agglutination of M-positive non-enzymatically glycosylated human red cells.Vox Sang 1981;41:85–90.10.1111/j.1423-0410.1981.tb01019.x7331284
  24. Vengelen-Tyler V, Dearolf SJ,Haley S.Two examples of antibodies dependent upon the presence of inosine. Transfusion 1981;21:315–9.10.1046/j.1537-2995.1981.21381201804.x7233514
  25. Nason S,Tyler V, Dugan M, Stefansson M.An unusual inhibition demonstrated with an anti-P1 (abstract).Transfusion 1978;18:638.
  26. Gillund TD, Howard PL, Isham B.A serum agglutinating human red cells exposed to EDTA.Vox Sang 1972;23:369–70.10.1111/j.1423-0410.1972.tb03473.x4628163
  27. Beck ML, Freihaut B, Henry R, Pierce S, Bayer WL.A serum haemagglutinating property dependent upon polycarboxyl groups. Br J Haematol 1975;29:149–56.10.1111/j.1365-2141.1975.tb01808.x32
  28. Howe SE, Sciotto CG, Berkner D.The role of carboxylic acids in EDTA-dependent panagglutination.Transfusion 1982;22:111–4.10.1046/j.1537-2995.1982.22282177115.x6803407
  29. Reid ME, Bottenfield LK,Toy PT, Ellisor SS,Hart CA. Agglutination of an EDTA blood sample caused by an EDTA-dependent panagglutinin. Am J Clin Pathol 1985;83:534–5.10.1093/ajcp/83.4.5343920896
  30. Parish HJ, Macfarlane RG. Effect of calcium in a case of autohaemagglutination. Lancet 1941; 2:477–9.
  31. Gunson HH.A serum agglutinin inhibited by ionized calcium.Vox Sang 1969;17:514–24.10.1111/j.1423-0410.1969.tb00426.x4984681
  32. Clarke U, Burger D, Botha I,May R.A citrate-dependent red cell antibody reactive only in bromelin (letter).Transfusion 1989;29:278.10.1046/j.1537-2995.1989.29389162741.x2922796
  33. Joshi SR. Citrate-dependent auto-antibody causing error in blood grouping. Vox Sang 1997;72:229–32.10.1159/000461999
  34. Tedrow HE, Zeigler ZR. Evidence of an anti-A1 inhibited by EDTA.Transfusion 1988;28:177–8.10.1046/j.1537-2995.1988.28288179026.x3127970
  35. Green ED,Curtis BR, Issitt PD,et al. Inhibition of an anti-Pr1d cold agglutinin by citrate present in commercial red cell preservative solutions.Transfusion 1990;30:267–70.10.1046/j.1537-2995.1990.30390194352.x2316003
  36. Beattie KM, Zuelzer WW.A serum factor reacting with acriflavine causing an error in ABO cell grouping.Transfusion 1968;8:254–7.10.1111/j.1537-2995.1968.tb02418.x5671551
  37. Beattie KM, Seymour DS, Scott A. Two further examples of acriflavine antibody causing ABO cell typing errors.Transfusion 1971;11:107–9.10.1111/j.1537-2995.1971.tb04385.x5313604
  38. Jones TE, Ayrton AS, Blajchman MA. Anomalous ABO grouping due to a new serum factor reactive with a reagent coloring material. Transfusion 1973;13:150–2.10.1111/j.1537-2995.1973.tb05463.x4711008
  39. Reviron M, Janvier D, Reviron J, Lagabrielle JF.An anti-I cold auto-agglutinin enhanced in the presence of sodium azide.Vox Sang 1984;46:211–6.10.1111/j.1423-0410.1984.tb00077.x6369782
  40. Weiner W,Tovey GH, Gillespie EM,et al. ”Albumin” auto-agglutinating property in three sera.Vox Sang 1956;1:279.
  41. McGinniss MH. The albumin autoagglutination phenomenon. In:A seminar on problems encountered in pretransfusion tests. Washington, D.C.: American Association of Blood Banks, 1972:107–16.
  42. Reid ME, Ellisor SS, Frank BA. Another potential source of error in Rh-hr typing. Transfusion 1975;15:485–8.10.1046/j.1537-2995.1975.15576082226.x812220
  43. Case J.Albumin autoagglutinating phenomenon as a factor contributing to false positive reactions when typing with rapid slide-test reagents. Vox Sang 1976;30:441–4.10.1111/j.1423-0410.1976.tb02849.x818812
  44. Yokoyama M, Park HS, Mermod L. Agglutinating activity of a healthy donor serum in the presence of albumin.Vox Sang 1968;14:67–9.10.1111/j.1423-0410.1968.tb01705.x
  45. Golde DW, Greipp PR, McGinniss MH.Spectrum of albumin auto-agglutinins.Transfusion 1973;33:1–5.10.1111/j.1537-2995.1973.tb05428.x4685219
  46. Golde DW, McGinniss MH, Holland PV. Serum agglutinins to commercially prepared albumin.Am J Clin Pathol 1971;55:655–8.10.1093/ajcp/55.6.6554999087
  47. Spence L, Jones D, Moore BPL. Effect of fatty acid salts on reactivity of albumin preparations with sera containing albumin auto-agglutinating factor. Transfusion 1971;11:193–5.10.1111/j.1537-2995.1971.tb04400.x5569032
  48. Beck ML, Edwards RL, Pierce SR, Hicklin BL, Bayer WL. Serologic activity of fatty acid dependent antibodies in albumin-free systems. Transfusion 1976;16:434–6.10.1046/j.1537-2995.1976.16577039298.x982535
  49. Beck ML, McGuire D, Richardson C.A fatty-acid dependent antibody with Rh specificity. Joint Congress of the American Association of Blood Banks and International Society of Blood Banks Book of Abstracts 1972:6.
  50. Dube VE, Zoes C,Adesman P. Caprylate-dependent auto-anti-e.Vox Sang 1977;33:359–63.10.1111/j.1423-0410.1977.tb02257.x412322
  51. Hossaini AA, Hazeghi K, Amiri P. Experimental induction of caprylate-dependent albumin anti-bodies.Transfusion 1977;17:54–8.10.1046/j.1537-2995.1977.17177128886.x841674
  52. Simmons A, Jones J, Hendrix D. Gamma globulin contamination of commercial bovine albumin. Transfusion 1973;13:142–5.10.1111/j.1537-2995.1973.tb05461.x4123043
  53. Hirayama C,Tamura N, Suou T.Serum antibodies to albumins in normal human pregnancy. Immunological Communications 1981;10:401–6.10.3109/088201381090507057333636
  54. Atkinson MA, Bowman MA, Kao KJ,et al. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 1993;329:1853–8.10.1056/NEJM1993121632925058247037
  55. Tomasi TB Jr, Katz L. Human antibodies against bovine immunoglobulin in IgA deficient sera. Clin Exp Immunol 1971;9:3–10.
  56. Huntley CC, Robbins JB, Lyerly AD, Buckley RH. Characterization of precipitating antibodies to ruminant serum and milk proteins in humans with selective IgA deficiency. N Engl J Med 1971;284:7–10.10.1056/NEJM1971010728401024992076
  57. Halima D,Garratty G, Bueno R.An apparent anti-Jka reacting only in the presence of methyl esters of hydroxybenzoic acid.Transfusion 1982;22:521–4.10.1046/j.1537-2995.1982.22683068617.x7147330
  58. Judd WJ, Steiner EA, Cochran RK.Paraben-associated auto-, anti-Jka antibodies. Three examples detected using commercially prepared low-ionicstrength saline containing parabens. Transfusion 1982;22:31–5.10.1046/j.1537-2995.1982.22182154211.x7064203
  59. Shirey S, Harris J, Moore L.An autoanti-I greatly enhanced in the presence of thimerosal (abstract). Transfusion 1979;19:642.
  60. Shulman IA, Hasz LA, Simpson RB. Thimerosal dependent agglutination,a newly described blood bank problem.Transfusion 1983;22:241–3.10.1046/j.1537-2995.1982.22382224950.x7090037
  61. Shulman IA, Simpson RB, Farmer CF, Lam HT. Thimerosal-dependent agglutination complicating the serologic evaluation for unexpected antibodies.Transfusion 1984;24:365–7.10.1046/j.1537-2995.1984.24484275584.x6464162
  62. Mason JM, Osborne PT, Hall AJ. Example of a thimerosal-dependent antibody without apparent blood group specificity.Vox Sang 1985;48:313–6.10.1111/j.1423-0410.1985.tb00188.x3992969
  63. Spencer GT, McDowell MA.Thimerosal-dependent antibody enhanced in the presence of LISS. Vox Sang 1985;49:422–3.
  64. Valbonesi M, Vassallo F, Lercari G, Frisoni R, Carubia F, Russo E.Two further examples of IgG thimerosal-dependent antibodies and their serological characteristics.Ric Clin Lab 1987;17:47–51.10.1007/BF029093883589402
  65. Lown JAG, Ivey JG.An unusual thimerosal-associated antibody reacting only by the Polybrene technique (letter).Transfusion 1990;30:667.10.1046/j.1537-2995.1990.30790385529.x2402780
  66. Arndt P, Hunt P, Garratty G, Miles M, Starrette K.Rh alloantibodies enhanced by thimerosal (abstract). Transfusion 1997;37(Suppl):S134.10.1046/j.1537-2995.1997.37111298088058.x9426652
  67. Malyska H, Kleeman JE, Masouredis SP,Victoria EJ. Effects on blood group antigens from storage at low ionic strength in the presence of neomycin. Vox Sang 1983;44:375–84.10.1111/j.1423-0410.1983.tb03660.x6308913
  68. Shirey RS, Ciappi AB, Kickler TS,Triulzi D, Ness PM. Compatibility testing problems associated with bovine thrombin-treated plasma. Immunohematology 1993;9:19–21.10.21307/immunohematology-2019-951
  69. Howell ED, Perkins HA. Anti-N-like antibodies in the sera of patients undergoing chronic hemodialysis.Vox Sang 1972;23:291–9.10.1111/j.1423-0410.1972.tb03463.x4562888
  70. McLeish WA, Brathwaite AF, Peterson PM. Anti-N antibodies in hemodialysis patients. Transfusion 1975;15:43–5.10.1046/j.1537-2995.1975.15175103509.x1114513
  71. Harrison PB, Jansson K, Kronenberg H, Mahony JF, Tiller D. Cold agglutinin formation in patients undergoing haemodialysis. A possible relationship to dialyser re-use.Aust NZ J Med 1975;5:195–7.10.1111/j.1445-5994.1975.tb04567.x1100029
  72. Crosson JT, Moulds J, Comty CM, Polesky HF.A clinical study of anti-NDP in the sera of patients in a large repetitive hemodialysis program. Kidney Intl 1976;10:463–70.10.1038/ki.1976.1331011540
  73. Boettcher B, Nanra RS, Roberts TK, Mallan M, Watterson CA. Specificity and possible origin of anti-N antibodies developed by patients undergoing chronic haemodialysis. Vox Sang 1976;31: 408–15.10.1111/j.1423-0410.1976.tb04455.x1007165
  74. Orringer EP, Mattern WD. Formaldehyde-induced hemolysis during chronic hemodialysis. N Engl J Med 1976;294:1416–20.10.1056/NEJM197606242942602178999
  75. Gorst DW, Riches RA, Renton PH. Formaldehyde-induced anti-N: a possible cause of renal graft failure.J Clin Pathol 1977;30:956–9.10.1136/jcp.30.10.956476604338635
  76. Sandler SG, Sharon R, Stessman J, Czaczkes JW. Antiformaldehyde and anti-N-like antibodies in hemodialysis patients. Israel J Med Sci 1978;14:1177–80.
  77. Fassbinder W, Seidel S, Koch KM. The role of formaldehyde in the formation of hemodialysis-associated anti-N-like antibodies. Vox Sang 1978;35:41–8.10.1111/j.1423-0410.1978.tb02899.x566486
  78. Sandler SG, Sharon R, Bush M, Stroup M, Sabo M. Formaldehyde-related antibodies in hemodialysis patients.Transfusion 1979;19:682–7.10.1046/j.1537-2995.1979.19680104093.x574996
  79. Sharon R. Reduced antibody response in patients with chronic renal failure undergoing hemodialysis with formaldehyde sterilized units.Transfusion 1979;19:754–5.10.1046/j.1537-2995.1979.19680104103.x574997
  80. Fassbinder W, Frei U, Koch KM. Haemolysis due to formaldehyde-induced anti-N-like antibodies in haemodialysis patients. Klin Wochenschr 1979; 57:673–9.10.1007/BF01477668573350
  81. Sharon R. Relationship between formaldehyde-related antibodies and cross-reacting anti-N-like antibodies in patients undergoing chronic haemodialysis. J Clin Pathol 1981;34:41–3.10.1136/jcp.34.1.4111464067053234
  82. Lown JAG, Barr AL, Kelly A. Auto anti-M antibody following renal transplantation. Vox Sang 1980; 38:301–4.10.1111/j.1423-0410.1980.tb04495.x7001749
  83. Lynen R, Rothe M, Gallasch E. Characterization of formaldehyde-related antibodies encountered in hemodialysis patients at different stages of immunization.Vox Sang 1983;44:81–9.10.1111/j.1423-0410.1983.tb04106.x6402858
  84. Dzik WH, Darling CA. Positive direct antiglobulin test result in dialysis patients resulting from antiformaldehyde antibodies. Am J Clin Pathol 1989;92:214–7.10.1093/ajcp/92.2.2142756937
  85. Belzer FO, Kountz SL, Perkins HA. Red cell cold autoagglutinins as a cause of failure of renal allotransplantation.Transplantation 1971;11:422–4.
  86. Simmons M, Stapleton RR, Brazier DM, Goldsmith KLG.An example of an anti-antibody causing difficulty in ABO grouping.Vox Sang 1971;21:284–7.10.1111/j.1423-0410.1971.tb00585.x
  87. Wilkinson SL, Vaithianathan T, Issitt PD. The high incidence of anti-HL-A antibodies in anti-D typing reagents. Illustrated by a case of Matuhasi-Ogata phenomenon mimicking a “D with anti-D” situation.Transfusion 1974;14:27–33.10.1111/j.1537-2995.1974.tb04480.x
  88. Cross RA. Incompatible crossmatches due to red cells stored in plastic packs. Aust J Med Tech 1979;10:169–70.
  89. Callahan JT, Collecutt MF, Lightbody JR, Faragher BS. Alteration of human red blood cells stored in plastic packs.Transfusion 1982;22:154–7.10.1046/j.1537-2995.1982.22282177125.x
  90. Bruce M, Crawford RJ, Mitchell R, Giles CM. An acquired red cell antigen derived from PVC blood packs. Med Lab Sci 1980;37:171–2.
  91. Bruce M, Mitchell R.The LOX antigen: a new chemically-induced red cell antigen. Med Lab Sci 1981;38:177–86.
  92. Harboe M, Reinskou T, Heistö H, Björnstad P. Studies on a serum with peculiar haemagglutinating properties. Vox Sang 1961;6:409–38.10.1111/j.1423-0410.1961.tb03187.x
  93. Heni F, Blessing K. Pannagglutination, Eigenagglutination der gewasche-nen Patienten-Blutkörperchen und Agglutinationshemmung durch Plasma-albumin bei erworbener hämolytis-cher Anämie.Acta Haematol 1952;8:232–45.10.1159/000204165
  94. Freisleben E, Jensen KG.An antibody specific for washed red cells. Proc. 7th Congr. Europ. Soc. Haematol. London, 1959.
  95. Allan CJ, Lawrence RD, Shih SC, Williamson KR, Sweatt MA, Taswell HF. Agglutination of erythrocytes freshly washed with saline solution. Transfusion 1972;12:306–11.10.1111/j.1537-2995.1972.tb04449.x
  96. Davey RJ,O’Gara C, McGinniss MH.Incompatibility in vitro and in vivo demonstrated only with saline-suspended red cells.Vox Sang 1979;36:301–6.10.1111/j.1423-0410.1979.tb04438.x
  97. Scarth I, Jones T. Investigation of a serum with peculiar agglutinating properties. Canad J Med Tech 1981;43:261–4.
  98. Garratty G, Davis J,Myers M.IgG red cell sensitization associated with in vitro clotting in patients with ulcerative colitis (abstract). Transfusion 1980;20:646.
  99. Tregellas WM, Lavine KK. Elucidation of a mechanism for serum reactivity and plasma non-reactivity of certain antibodies (abstract). Transfusion 1982;22:406.
  100. Tregellas WM, Holub MP, Moulds JJ, Lacey PA.An example of autoanti-Sc1 demonstrable in serum but not in plasma (abstract). Transfusion 1979;19:650.
  101. Garratty G.In vitro IgG sensitization of red cells associated with ulcerative colitis and serine proteases (abstract).Transfusion 1993(Suppl);33:22S.
  102. Moses BH, South SF, Ubbelohde M.Serum reactive, plasma nonreactive autoanti-Kel4 (Kpb) (abstract). Transfusion 1991(Suppl);31:26S.
  103. South SF, Davis K. Serum-reactive, plasma-nonreactive autoanti-c (abstract). Transfusion 1993(Suppl);33:22S.
  104. Menitove J,ed.Standards for blood banks and transfusion services. 18th ed. Bethesda, MD: American Association of Blood Banks, 1997.
  105. Brendemoen OJ. A cold agglutinin specifically active against stored red cells.Acta Path Microbiol Scand 1952;31:574–8.10.1111/j.1699-0463.1952.tb00224.x
  106. Stratton F, Renton PH, Rawlinson VI. Serological difference between old and young cells. Lancet 1960;1:1388–90.10.1016/S0140-6736(60)91157-0
  107. Jenkins WJ, Marsh WL. Autoimmune haemolytic anaemia. Lancet 1961;2:16–8.
  108. Ozer FL, Chaplin H Jr. Agglutination of stored erythrocytes by a human serum. Characterization of the serum factor and erythrocyte changes. J Clin Invest 1963;42:1735–52.10.1172/JCI10485928945714083164
  109. Beaumont JL, Lorenzelli L, Delplanque B, et al.A new serum lipoprotein associated erythrocyte antigen which reacts with a monoclonal IgM.Vox Sang 1976;30:36–49.10.1111/j.1423-0410.1976.tb04832.x175578
  110. Linder E, Edington TS. Immunobiology of the autoantibody response.II.The lipoprotein-associated soluble HB erythrocyte autoantigen of NZB mice. J Immunol 1973;110:53.
  111. Lightwood AM, Scott GL. Autoimmune haemolytic anaemia due to red cell antibodies of different specificities in a patient with chronic hepatitis.Vox Sang 1973;24:331–6.10.1111/j.1423-0410.1973.tb02650.x4691231
  112. Easton JA, Priest CJ, Giles CM.An antibody against stored blood associated with cirrhosis of the liver and false-positive serological tests for syphilis. J Clin Pathol 1965;18:460–1.10.1136/jcp.18.4.46047298014318700
  113. Arndt P, O’Hoski P, McBride J, Garratty G. Autoimmune hemolytic anemia associated with an antibody reacting preferentially with “old”red cells (abstract).Transfusion 1989(Suppl);29:48S.
  114. Kay MMB. Senescent cell antigen: a red cell aging antigen. In: Garratty G, ed. Red cell antigens and antibodies.Arlington,VA:American Association of Blood Banks, 1986:35–82.
  115. Branch DR, Shulman IA,Sy Siok Hian AL, Petz LD. Two distinct categories of warm autoantibody reactivity with age-fractionated red cells. Blood 1984;63:177–80.10.1182/blood.V63.1.177.177
DOI: https://doi.org/10.21307/immunohematology-2019-646 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 1 - 11
Published on: Nov 3, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 G. Garratty, published by American National Red Cross
This work is licensed under the Creative Commons License.